Skip to main content

Table 1 Baseline demographics and baseline characteristics of the study groups

From: Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study

 

Glimepiride

Vildagliptin

n

22

22

Male / female

13 / 9

15 / 7

Age (years)

60 ± 7

57 ± 9

Duration of diabetes (years)

6.1 ± 4.4

8.4 ± 9.0 $

HbA1c (%)

7.3 ± 0.6

7.4 ± 0.7

BMI (kg/m2)

33.3 ± 6.7

34.6 ± 5.9

  1. mean ± SD; $ = p < 0.05 in between both groups.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840